Tokyo, Japan and Cambridge, UK, 23 January 2025 - Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) will announce its earnings results and present operational highlights for the year ended 31 December 2024 on ...

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug ...

From AI-driven patient avatars to interactive augmented reality scenarios, learn about the hottest new virtual tools that are setting the standard for Life Science education and training in 2025. Step ...

Both webinars will highlight how RADR ®, Lantern’s AI platform, has been used to advance their portfolio and the portfolio of their collaborators. On October 28 th, Lantern’s CEO Panna Sharma will ...

Little Green Pharma Ltd. (AU:LGP) has released an update. Little Green Pharma Ltd. is hosting an investor webinar where CEO Paul Long will present the Quarterly Activities Report for September 2024.

For more information, or to register for this event, visit Overcoming Pharmaceutical Supply Chain Risks with AI Tools.

Mayne Pharma Group (AU:MYX) has released an update. Mayne Pharma Group is hosting an investor webinar focusing on its US Women’s Health and Dermatology businesses, featuring insights from top ...

WOBURN, Mass.--(BUSINESS WIRE)--We are pleased to announce that Aphios Pharma LLC will host a live webinar followed by Q&A on the science and technology of cannabis as a medicine. This webinar will ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Elemental Impurities: The New Requirements" webinar to their offering. This webinar is designed to provide a ...

PITTSBURGH, May 13, 2011 (GLOBE NEWSWIRE) -- From research and development to manufacturing, pharmaceutical companies spend billions of dollars to bring new drug products to market and sustain the ...

DALLAS--(BUSINESS WIRE)-- Lantern Pharma Inc., an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery ...